178 related articles for article (PubMed ID: 21735096)
41. Structure-based Discovery of Novel CK2α-Binding Cyclic Peptides with Anti-cancer Activity.
Tang S; Zhang N; Zhou Y; Cortopassi WA; Jacobson MP; Zhao LJ; Zhong RG
Mol Inform; 2019 Mar; 38(3):e1800089. PubMed ID: 30307134
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of protein kinase CK2 expression and activity blocks tumor cell growth.
Zhu D; Hensel J; Hilgraf R; Abbasian M; Pornillos O; Deyanat-Yazdi G; Hua XH; Cox S
Mol Cell Biochem; 2010 Jan; 333(1-2):159-67. PubMed ID: 19629644
[TBL] [Abstract][Full Text] [Related]
43. Unbiased functional proteomics strategy for protein kinase inhibitor validation and identification of bona fide protein kinase substrates: application to identification of EEF1D as a substrate for CK2.
Gyenis L; Duncan JS; Turowec JP; Bretner M; Litchfield DW
J Proteome Res; 2011 Nov; 10(11):4887-901. PubMed ID: 21936567
[TBL] [Abstract][Full Text] [Related]
44. Effects of interphase and mitotic phosphorylation on the mobility and location of nucleolar protein B23.
Negi SS; Olson MO
J Cell Sci; 2006 Sep; 119(Pt 17):3676-85. PubMed ID: 16912078
[TBL] [Abstract][Full Text] [Related]
45. Nuclear export of S6K1 II is regulated by protein kinase CK2 phosphorylation at Ser-17.
Panasyuk G; Nemazanyy I; Zhyvoloup A; Bretner M; Litchfield DW; Filonenko V; Gout IT
J Biol Chem; 2006 Oct; 281(42):31188-201. PubMed ID: 16895915
[TBL] [Abstract][Full Text] [Related]
46. Protein kinase CK2 interacts with adiponectin receptor 1 and participates in adiponectin signaling.
Heiker JT; Wottawah CM; Juhl C; Kosel D; Mörl K; Beck-Sickinger AG
Cell Signal; 2009 Jun; 21(6):936-42. PubMed ID: 19233263
[TBL] [Abstract][Full Text] [Related]
47. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
Leung KK; Shilton BH
Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
[TBL] [Abstract][Full Text] [Related]
48. Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction.
Laudet B; Barette C; Dulery V; Renaudet O; Dumy P; Metz A; Prudent R; Deshiere A; Dideberg O; Filhol O; Cochet C
Biochem J; 2007 Dec; 408(3):363-73. PubMed ID: 17714077
[TBL] [Abstract][Full Text] [Related]
49. Identification of hematein as a novel inhibitor of protein kinase CK2 from a natural product library.
Hung MS; Xu Z; Lin YC; Mao JH; Yang CT; Chang PJ; Jablons DM; You L
BMC Cancer; 2009 May; 9():135. PubMed ID: 19419583
[TBL] [Abstract][Full Text] [Related]
50. Protein kinase CK2 catalyzes tyrosine phosphorylation in mammalian cells.
Vilk G; Weber JE; Turowec JP; Duncan JS; Wu C; Derksen DR; Zien P; Sarno S; Donella-Deana A; Lajoie G; Pinna LA; Li SS; Litchfield DW
Cell Signal; 2008 Nov; 20(11):1942-51. PubMed ID: 18662771
[TBL] [Abstract][Full Text] [Related]
51. Protein kinase CK2 phosphorylates and upregulates Akt/PKB.
Di Maira G; Salvi M; Arrigoni G; Marin O; Sarno S; Brustolon F; Pinna LA; Ruzzene M
Cell Death Differ; 2005 Jun; 12(6):668-77. PubMed ID: 15818404
[TBL] [Abstract][Full Text] [Related]
52. Protein kinase CK2 is inhibited by human nucleolar phosphoprotein p140 in an inositol hexakisphosphate-dependent manner.
Kim YK; Lee KJ; Jeon H; Yu YG
J Biol Chem; 2006 Dec; 281(48):36752-7. PubMed ID: 17038328
[TBL] [Abstract][Full Text] [Related]
53. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells.
Apopa PL; He X; Ma Q
J Biochem Mol Toxicol; 2008 Feb; 22(1):63-76. PubMed ID: 18273910
[TBL] [Abstract][Full Text] [Related]
54. Enhanced binding of RNAP II CTD phosphatase FCP1 to RAP74 following CK2 phosphorylation.
Abbott KL; Renfrow MB; Chalmers MJ; Nguyen BD; Marshall AG; Legault P; Omichinski JG
Biochemistry; 2005 Mar; 44(8):2732-45. PubMed ID: 15723518
[TBL] [Abstract][Full Text] [Related]
55. A FRET-based microplate assay for human protein kinase CK2, a target in neoplastic disease.
Gratz A; Götz C; Jose J
J Enzyme Inhib Med Chem; 2010 Apr; 25(2):234-9. PubMed ID: 19874207
[TBL] [Abstract][Full Text] [Related]
56. Reduced phosphorylation of Stat3 at Ser-727 mediated by casein kinase 2 - protein phosphatase 2A enhances Stat3 Tyr-705 induced tumorigenic potential of glioma cells.
Mandal T; Bhowmik A; Chatterjee A; Chatterjee U; Chatterjee S; Ghosh MK
Cell Signal; 2014 Aug; 26(8):1725-34. PubMed ID: 24726840
[TBL] [Abstract][Full Text] [Related]
57. Antitumor efficacy, pharmacokinetic and biodistribution studies of the anticancer peptide CIGB-552 in mouse models.
Vallespí MG; Pimentel G; Cabrales-Rico A; Garza J; Oliva B; Mendoza O; Gomez Y; Basaco T; Sánchez I; Calderón C; Rodriguez JC; Markelova MR; Fichtner I; Astrada S; Bollati-Fogolín M; Garay HE; Reyes O
J Pept Sci; 2014 Nov; 20(11):850-9. PubMed ID: 25044757
[TBL] [Abstract][Full Text] [Related]
58. Enhancing the apoptotic potential of insulin-like growth factor-binding protein-3 in prostate cancer by modulation of CK2 phosphorylation.
Cobb LJ; Mehta H; Cohen P
Mol Endocrinol; 2009 Oct; 23(10):1624-33. PubMed ID: 19556345
[TBL] [Abstract][Full Text] [Related]
59. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
Gyenis L; Turowec JP; Bretner M; Litchfield DW
Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
[TBL] [Abstract][Full Text] [Related]
60. Compartmentation of the nucleolar processing proteins in the granular component is a CK2-driven process.
Louvet E; Junéra HR; Berthuy I; Hernandez-Verdun D
Mol Biol Cell; 2006 Jun; 17(6):2537-46. PubMed ID: 16540521
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
